No prior treatment (ex. radiation therapy, chemotherapy, hormonal therapy) to advanced disease. Patients who received adjuvant chemotherapy more than 180 days before enrollment can be allowed but those who received S-1 or Oxaliplatin containing treatment shall be excluded.
At least one measurable lesion by RECIST criteria
You may not be if
Serious drug hypersensitivity.
Prior history of peripheral neuropathy.
Diarrhea .
Simultaneously active double cancer.
Clareo Health | Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer
